FDA NDC Directory · JSON-LD · Markdown

Adalimumab

NDC 61314-325 · HUMAN PRESCRIPTION DRUG · INJECTION, SOLUTION

Generic nameadalimumab-adaz
Labeler / ManufacturerSandoz Inc
Marketing categoryBiologic License Application · App BLA761071
Dosage form / routeINJECTION, SOLUTION · SUBCUTANEOUS
Active ingredientsADALIMUMAB (80 mg/.8mL)
Marketing started20250106
Package count1

External sources

Source: openFDA. Public-domain (CC0).